Skip to content

Innoviva, Inc. INVA Accounts Payable

Accounts Payable at other companies

Pfizer logo
PfizerPFE
$4.51B-14.0%
Merck & Co. logo
Merck & Co.MRK
$3.86B+2.1%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$26.03M+49.1%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$8.73M+100.0%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$5.26M-1.9%
Alkermes logo
AlkermesALKS
$292.58M+57.3%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s accounts payable?
Innoviva, Inc. (INVA) reported accounts payable of $6.52M in Q1 2026.
How has Innoviva, Inc.'s accounts payable changed year-over-year?
Innoviva, Inc.'s accounts payable increased by 38.7% year-over-year, from $4.7M to $6.52M.
What is the long-term trend for Innoviva, Inc.'s accounts payable?
Over 5 years (2020 to 2025), Innoviva, Inc.'s accounts payable has grown at a 137.3% compound annual growth rate (CAGR), from $66K to $4.97M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.